Search

Displaying results 5401 - 5410 of 10000 in total
  1. Drug

    Sodium metavanadate

    go.drugbank.com/drugs/DB14702
    Approved

    Mixtures: Multivitamins and Minerals Tablets, Milltrium Senior Vitamin and Mineral Supplement
  2. Drug

    Morrhuic acid

    go.drugbank.com/drugs/DB14087
    Investigational

    Morrhuic acid is a mixture of unsaturated fatty acids obtained from cod liver oil.

  3. Drug

    Torcetrapib

    go.drugbank.com/drugs/DB06281
    Investigational

    of atorvastatin and the study drug. … Torcetrapib (CP-529414, Pfizer) was developed to treat hypercholesterolemia but its development was halted in 2006 when phase III studies showed excessive mortality in the treatment group receiving a combination

  4. Drug

    Goserelin

    go.drugbank.com/drugs/DB00014
    ApprovedInvestigational

    Goserelin is a synthetic hormone. In men, it stops the production of the hormone testosterone, which may stimulate the growth of cancer cells. In women, goserelin decreases the production of the hormone estradiol (which may stimulate the...

    Categories: Hormones and Related Agents, Amino Acids, Peptides, and Proteins
  5. Drug

    Zaleplon

    go.drugbank.com/drugs/DB00962
    ApprovedIllicit

    Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States.

    Categories: Hypnotics and Sedatives, Benzodiazepine hypnotics and sedatives
  6. Drug

    Fluasterone

    go.drugbank.com/drugs/DB06250
    Experimental

    Has antiproliferative effects on HIV-1 and reduces HIV-1 replication.

    Categories: Hormones, Hormone Substitutes, and Hormone Antagonists
  7. Drug

    Lys-plasminogen

    go.drugbank.com/drugs/DB32870
    Experimental

    Lys-plasminogen is a truncated form of natural human plasminogen.

    Categories: Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins
  8. Drug

    Brilaroxazine

    go.drugbank.com/drugs/DB09226
    Investigational

    Brilaroxazine (RP5063) is an investigational atypical antipsychotic which is under development by Reviva Pharmaceuticals for the treatment of schizophrenia and schizoaffective disorder. … /ADHD), and autism.

  9. Drug

    AC3056

    go.drugbank.com/drugs/DB05230
    Experimental

    It as since been acquired by Amylin Pharmaceuticals and has completed phase I trials. … AC3056 is a non-peptide antioxidant that acts as an inhibitor of vascular cell adhesion molecule expression originally developed by Aventis Pharmaceuticals.

  10. Drug

    Lactobacillus coryniformis K8

    go.drugbank.com/drugs/DB15733
    Experimental

    Lactobacillus is a common bacteria found in the gut with Lactobacillus coryniformis K8 being originally isolated from artisan goat cheese.